<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC7102570/results/search/country/results.xml">
  <result pre="trials of treatments for seasonal influenza have been performed in" exact="Japan" post="and US, and favipiravir was approved as a treatment"/>
  <result pre="as a treatment for novel or re-emerging influenza viruses in" exact="Japan" post="in 2014. Favipiravir is considered for administration to patients"/>
  <result pre="al., 2016). Since children died of avian influenza A(H5N1) in" exact="Hong Kong" post="in 1997 (Ku &amp;amp; Chan, 1999), concern regarding novel"/>
  <result pre="has been used to treat patients with severe influenza in" exact="China" post="(Cao, 2018; Wang et al., 2019). Although each novel"/>
  <result pre="trials of treatments for seasonal influenza have been performed in" exact="Japan" post="and the US, and favipiravir was approved as a"/>
  <result pre="treatments for seasonal influenza have been performed in Japan and" exact="the US," post="and favipiravir was approved as a treatment for novel"/>
  <result pre="as a treatment for novel or re-emerging influenza viruses in" exact="Japan" post="in 2014. However, favipiravir (Avigan®) is only considered for"/>
  <result pre="been performed to assess its efficacy in treating SFTS in" exact="Japan" post="(Yasukawa, 2016) and as a combination therapy with oseltamivir"/>
  <result pre="therapy with oseltamivir to treat patients with severe influenza in" exact="China" post="(Cao, 2018; Wang et al., 2019). In addition to"/>
  <result pre="possessing an NA H275Y substitution spread globally, 12.3% (142/1155) in" exact="the US" post="(Dharan et al., 2009), 64% in South Africa, Oceania"/>
  <result pre="(142/1155) in the US (Dharan et al., 2009), 64% in" exact="South Africa," post="Oceania and SE Asia (Hurt et al., 2009), and"/>
  <result pre="have elapsed since an avian influenza case was reported in" exact="Hong Kong" post="in 1997, and a decade has elapsed since the"/>
  <result pre="treating patients with severe influenza in combination with oseltamivir in" exact="China" post="(Cao, 2018; Wang et al., 2019). Favipiravir and oseltamivir"/>
  <result pre="day for 9 days, and the approved favipiravir dose in" exact="Japan" post="is 1600 mg twice a day on day 1"/>
  <result pre="model (Smither et al., 2014). An Ebola study conducted in" exact="Guinea" post="included 126 patients, and 111 were analyzed and compared"/>
  <result pre="significant (Sissoko et al., 2016). An Ebola study conducted in" exact="Sierra Leone" post="included 39 favipiravir-treated patients and 85 historical control patients."/>
  <result pre="clinical recovery compared to oseltamivir monotherapy in severe influenza in" exact="China" post="(Cao, 2018; Wang et al., 2019). 5.4 The dose"/>
  <result pre="mg package insert). The approved favipiravir dose for influenza in" exact="Japan" post="is 1600 mg twice a day on day 1"/>
  <result pre="al., 2013). Since children died of avian influenza A(H5N1) in" exact="Hong Kong" post="in 1997 (Ku &amp;amp; Chan, 1999), concern has been"/>
  <result pre="Novartis, and research funding from Maruho Co., Ltd., MSD, and" exact="Japan" post="Blood Products Organization; all payments were sent to the"/>
  <result pre="Favipiravir (T-705)-Sierra Leone, 2014Clinical Infectious Diseases6320161288129427553371 BakerL.Bat rabies outbreak in" exact="Peru" post="claims one, but others survive: Mass vaccination campaign underwayhttps://rabiesalliance.org/resource/bat-rabies-outbreak-peru-claims-one-others-survive-mass-vaccination-campaign-underway2017"/>
  <result pre="among RNA virusesProceedings of the National Academy of Sciences of" exact="the United States" post="of America901993417141758387212 ElionG.B.Mechanism of action and selectivity of acyclovirThe"/>
  <result pre="RNA virusesProceedings of the National Academy of Sciences of the" exact="United States" post="of America901993417141758387212 ElionG.B.Mechanism of action and selectivity of acyclovirThe"/>
  <result pre="a broad spectrum inhibitor of viral RNA polymeraseProceedings of the" exact="Japan" post="Academy. Series B, Physical and Biological Sciences932017449463 FurutaY.TakahashiK.FukudaY.KunoM.KamiyamaT.KozakiK. …ShirakiK.In"/>
  <result pre="favipiravir in influenzaProceedings of the National Academy of Sciences of" exact="the United States" post="of America1152018116131161830352857 GowenB.B.JuelichT.L.SefingE.J.BraselT.SmithJ.K.ZhangL. …FreibergA.N.Favipiravir (T-705) inhibits Junin virus infection"/>
  <result pre="in influenzaProceedings of the National Academy of Sciences of the" exact="United States" post="of America1152018116131161830352857 GowenB.B.JuelichT.L.SefingE.J.BraselT.SmithJ.K.ZhangL. …FreibergA.N.Favipiravir (T-705) inhibits Junin virus infection"/>
  <result pre="(T-705) inhibits Junin virus infection and reduces mortality in a" exact="Guinea" post="pig model of argentine hemorrhagic feverPLoS Neglected Tropical Diseases72013e2614"/>
  <result pre="influenza A virusesProceedings of the National Academy of Sciences of" exact="the United States" post="of America107201088288720080770 KuA.S.ChanL.T.The first case of H5N1 avian influenza"/>
  <result pre="A virusesProceedings of the National Academy of Sciences of the" exact="United States" post="of America107201088288720080770 KuA.S.ChanL.T.The first case of H5N1 avian influenza"/>
  <result pre="Lassa feverClinical Infectious Diseases65201785585929017278 RenaultP.JosseranL.PierreV.Chikungunya-related fatality rates, Mauritius, India, and" exact="Reunion" post="IslandEmerging Infectious Diseases1420081327 Rocha-PereiraJ.JochmansD.DallmeierK.LeyssenP.NascimentoM.S.NeytsJ.Favipiravir (T-705) inhibits in vitro norovirus"/>
  <result pre="syndromeAntimicrobial Agents and Chemotherapy5720134673468023856782 SafronetzD.RosenkeK.WestoverJ.B.MartellaroC.OkumuraA.FurutaY. …GowenB.B.The broad-spectrum antiviral favipiravir protects" exact="Guinea" post="pigs from lethal Lassa virus infection post-disease onsetScientific Reports520151477526456301"/>
  <result pre="the Ministry of Education, Culture, Sports, Science and Technology of" exact="Japan" post="and joint research project with Toyama Chemical Co., Ltd."/>
 </snippets>
</snippetsTree>
